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CASE REPORT
Hepatosplenic Sarcoidosis Complicated by Liver Cirrhosis
B. Peters*,†, F. M. Vanhoenacker*,†,‡, P. Bernard*, H. Van Dijck* and L. Van Overbeke*
Sarcoidosis is a multisystemic disease usually affecting the lungs and mediastinal lymph nodes. Other 
organs, such as the liver and the spleen, are less commonly involved. Patients usually present with mild 
nonspecific symptoms. On imaging, hepatosplenomegaly with or without multiple focal lesions within the 
spleen may be seen in the active disease stage. Rarely, the disease may evolve to cirrhosis and liver failure. 
We report such a rare case of hepatosplenic sarcoidosis complicated by acute esophageal bleeding due to 
portal hypertension.
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Introduction
Sarcoidosis is a multisystemic disease usually affecting the 
lungs and mediastinal lymph nodes. Other organs, such 
as the liver and the spleen, are less commonly involved. 
Patients usually present with mild nonspecific symp-
toms. On imaging, hepatosplenomegaly with or without 
multiple focal lesions within the spleen may be seen in 
the active disease stage. Rarely, the disease may evolve to 
cirrhosis and liver failure. We report such a rare case of 
hepatosplenic sarcoidosis complicated by acute esopha-
geal bleeding due to portal hypertension.
Case report
A 60-year-old women was admitted with fatigue and 
abdominal discomfort. Further clinical history was unre-
markable. Physical examination revealed epigastric ten-
derness. All laboratory test results were within normal 
range except for an elevated angiotensin-converting 
enzyme (ACE) 601 U/L (normal value: 115–419 U/L). 
Computed tomography (CT) (Fig. 1) and subsequent 
magnetic resonance imaging (MRI) (Fig. 2) were per-
formed. Both techniques showed multiple focal lesions 
of intermediate size throughout the liver and spleen. 
Moderately enlarged lymph nodes were seen at the ret-
roperitoneum and the lesser curvature of the stomach. 
Contrast-enhanced MRI after gadolinium-BOPTA admin-
istration showed hypo-enhancing lesions in the liver 
and spleen in the portal venous phase, whereas delayed 
phase one hour after injection could only demon-
strate persistent enhancement of the splenic lesions. 
CT of the thorax was non contributive, as it revealed only 
slightly enlarged mediastinal lymph nodes and question-
able thickening of the pleural fissures.
Although not supported by typical chest involvement, 
elevated ACE levels in combination with the imaging 
features of the upper abdominal organs were highly sug-
gestive for hepatosplenic sarcoidosis. Unfortunately, the 
patient refused diagnostic liver biopsy at that time and 
was lost from follow-up.
Four years later, she presented with esophageal variceal 
bleeding. The varices were ligated and the patient was 
stabilized. CT and MRI (Fig. 3) showed focal enlarge-
ment and irregular delineation of the caudate lobe and 
esophageal varices most compatible with liver cirrhosis. 
An ultrasound-guided biopsy showed periportal fibrosis 
(Fig. 4) in keeping with extinguished sarcoidosis. Because 
of the chronic nature of the disease, no further medical 
treatment with corticosteroids was initiated and waitful 
watching was recommended.
Discussion
Sarcoidosis is a multisystemic disease characterized by 
formation of non-caseating granulomas in various organs. 
The etiology is still debated, although many authors sug-
gest a combination of genetic susceptibility and environ-
mental factors [1].
Sarcoidosis has a global prevalence of 1–40 per 100 000, 
with the highest prevalence's observed in Scandinavian and 
African-Americans. It has a peak incidence between the third 
and fifth decade with a slight female predominance [1–2].
Lungs and mediastinal lymph nodes are involved in 
90% of the cases. Although the liver is the third most 
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Figure 1: Axial (A, B, and C) and coronal (D) contrast-enhanced CT of the abdomen in the portal venous phase at time 
of the initial diagnosis. (A) shows multiple hypodense lesions throughout the liver and the spleen. (B) and (C) demon-
strates lymph nodes of intermediate size (white arrow) at the retroperitoneum and along the lesser curvature of the 
stomach. The liver is slightly enlarged.
Figure 2: MRI of the upper abdomen at time of the initial diagnosis. Axial fat suppressed (FS) T2-weighted image (WI) (A), 
shows multiple hypointense liver and splenic lesions. Axial FS T1-WI before (B) and after administration of 
gadolinium-BOPTA contrast (C), show multiple hypointense focal lesions throughout the liver and spleen enhancing 
less than the surrounding liver and splenic parenchyma. FS T1-WI 1 hour after administration of gadolinium-BOPTA (D) 
shows delayed enhancement of the splenic lesions, whereas the liver lesions are not visible against the background 
of liverspecific enhancement of the normal liver.
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Figure 4: Sirius red staining. Portal tract is elongated due to connecting periportal fibrosis in keeping with stage F3 
liver fibrosis (Metavir classification).
Figure 3: Imaging examinations four years later: Axial (A) and coronal (B and D) contrast-enhanced CT of the abdomen 
in the portal venous phase. (A) shows a nodular contour of the liver with a relative enlarged caudate lobe. (B) shows 
multifocal hypodense splenic lesions. (C) demonstrates esophageal varices (black arrow). Axial FS T2-WI (D) shows a 
heterogeneity of the liver parenchyma with multiple relative hypointense lesions diffuse throughout the liver.
Peters et al: Hepatosplenic Sarcoidosis Complicated by Liver Cirrhosis56
affected organ, hepatosplenic sarcoidosis without lung 
involvement is uncommon [3].
The majority of the patients are asymptomatic or have 
mild, non-specific symptoms such as nausea, vomiting, 
weight loss and abdominal discomfort. 
Laboratory findings are non-specific as well. Non-
complicated patients with sarcoidosis have elevated ACE 
levels in 60% of cases. Thirty-five percent of patients have 
abnormal liver function tests, including raised alkaline 
phosphatase and gamma-glutamyltranspeptidase [4].
As the majority of patients with hepatosplenic sarcoido-
sis have chest involvement, plain radiography or even bet-
ter CT of the chest are recommended as the next step in 
the diagnostic algorithm of suspected hepatosplenic sar-
coidosis. Although hepatosplenic involvement is relatively 
frequent in patients with sarcoidosis, imaging of the liver 
and spleen is often normal. Only a minority of patients 
will present with abnormal findings on medical imaging. 
The most common imaging finding in hepatosplenic sar-
coidosis on ultrasound consists of hepatomegaly with or 
without retroperitoneal adenopathy. CT and T2-weighted 
MRI are more sensitive to detect non-caseating granulo-
mas as multiple hypodense or T2-hypointense nodules 
of intermediate size in 5–15% of cases [5]. These nodules 
show delayed contrast enhancement in the portal venous 
phase on both CT and MRI.
An additional point of interest in our case is the 
enhancement pattern of sarcoid lesions after Gd-BOPTA 
administration in the late phase imaging. Gd-BOPTA is an 
MR contrast agent with partial nonspecific and liverspe-
cific effect. Delayed enhancement of the sarcoid lesions 
compared to the normal splenic parenchyma results in a 
high contrast between the lesions and the normal spleen. 
On the contrary, accumulation of Gd-BOPTA in the hepat-
ocytes and bile ducts of the normal liver parenchyma 
hampers lesion conspicuity of hepatic sarcoid lesions in 
the hepatospecific phase.
The differential diagnosis of multifocal hepatic and 
splenic lesions includes metastases, multifocal lymphoma 
and fungal infection. Metastases should be considered as 
the preferred diagnosis if the patient has a known malig-
nancy. In multifocal liver lymphoma, focal hepatosplenic 
lesions are usually larger than in sarcoidosis and are asso-
ciated with more bulky adenopathy. Hepatosplenic lesions 
in fungal infection are typically smaller than in sarcoidosis 
and patients are often immunocompromised and are criti-
cally ill [6].
In only 1% of cases hepatosplenic sarcoidosis may be 
complicated by portal hypertension, cirrhosis and liver 
failure due to periportal fibrosis [7]. Histopathology 
is required for definite diagnosis of hepatosplenic 
sarcoidosis.
Medical treatment of active hepatosplenic sarcoidosis 
consists of prednisone 20–40 mg/day. Since most patients 
are asymptomatic or have only mild symptoms, potential 
side effects and therapeutic benefits of corticosteroids 
should be outweighted carefully [8–9].
Conclusion
Although sarcoidosis of the liver and spleen is well-known 
disease, symptomatic hepatosplenic sarcoidosis evolving 
to end stage liver disease is extremely rare and therefore 
a challenging diagnosis. The radiologist should consider 
this rare diagnosis in the appropriate clinical setting.
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